BIO972 Israel. Science. Community.
Do you have a hot news tip or opinion? Would you like to know more about our advertising opportunities? BIO972 welcomes all submissions, feedback and general inquiries. Fill out the form below and we will get back to you in a timely manner.
Don't Miss
- Teva Announces Sale of Pennsylvania Facility
- Byzantine Grape Seeds Discovered in the Negev
- Evogene to Build Research Facility in the United States
- MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week
- Evogene Incorporates Gene Optimization Program into Collaboration with Monsanto
- Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
- Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement
- Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue
- cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy
- Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa